CBDG (THC Farmaceuticals) Ending Cash Position: $0.00 Mil (As of Jun. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is THC Farmaceuticals Ending Cash Position?

THC Farmaceuticals CBDG Ending Cash Position is $0.00 Mil as of Jun. 2018.

THC Farmaceuticals's Ending Cash Position for the quarter that ended in Jun. 2018 was $0.00 Mil.

THC Farmaceuticals's quarterly Ending Cash Position stayed the same from Jun. 2017 ($0.00 Mil) to Mar. 2018 ($0.00 Mil) and stayed the same from Mar. 2018 ($0.00 Mil) to Jun. 2018 ($0.00 Mil).

THC Farmaceuticals's annual Ending Cash Position declined from Sep. 2011 ($0.00 Mil) to Sep. 2012 ($0.00 Mil) and declined from Sep. 2012 ($0.00 Mil) to Sep. 2013 ($0.00 Mil).

THC Farmaceuticals Ending Cash Position Related Terms

THC Farmaceuticals Ending Cash Position Historical Data

* Premium members only.

The historical data trend for THC Farmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Farmaceuticals Ending Cash Position Chart

THC Farmaceuticals Annual Data
Trend Sep10 Sep11 Sep12 Sep13
Ending Cash Position
0.01 0.00 0.00 0.00

THC Farmaceuticals Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Mar17 Jun17 Mar18 Jun18
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 -0.01 0.00 0.00 0.00

THC Farmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

THC Farmaceuticals's Ending Cash Position for the fiscal year that ended in Sep. 2013 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.003+-0.002
=0.00

THC Farmaceuticals's Ending Cash Position for the quarter that ended in Jun. 2018 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.002+0
=0.00

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.00 Mil mean?
THC Farmaceuticals (CBDG) has a Ending Cash Position of $0.00 Mil as of Jun. 2018. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on THC Farmaceuticals and its competitors.
Is THC Farmaceuticals' Ending Cash Position too high?
THC Farmaceuticals' current Ending Cash Position is $0.00 Mil.
How does THC Farmaceuticals' Ending Cash Position compare to BOXS?
THC Farmaceuticals' Ending Cash Position of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on THC Farmaceuticals and its competitors. THC Farmaceuticals's current Ending Cash Position is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is THC Farmaceuticals stock overvalued right now?
THC Farmaceuticals (CBDG) has a current Ending Cash Position of $0.00 Mil. The current Ending Cash Position is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For THC Farmaceuticals (CBDG), the current Ending Cash Position is $0.00 Mil as of Jun. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

THC Farmaceuticals Business Description

Address 2789 Rio Vista Drive, Suite 3, Saint George, UT, USA, 84790
THC Farmaceuticals Inc is a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology, and other medical disciplines. It offers the combination of proprietary developments with the expertise of clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive compounds.